Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Tuberculosis dissemination in kidney transplant recipient treated with anti-CD40 monoclonal antibody: a case report

K. Bednarova, J. Slatinska, O. Fabian, P. Wohl, E. Kopecka, O. Viklicky

. 2022 ; 23 (1) : 290. [pub] 20220819

Language English Country England, Great Britain

Document type Case Reports, Journal Article, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc22024799

BACKGROUND: Tuberculosis (TBC) in solid organ transplant recipients represents a severe complication. The incidence among transplant recipients is higher than in the general population, and the diagnosis and treatment remain challenging. We present a case of active disseminated tuberculosis in a kidney transplant recipient treated with an anti-CD40 monoclonal antibody, who had been previously exposed to an active form of the disease, but latent tuberculosis (LTBI) was repeatedly ruled out prior to transplantation. To the best of our knowledge, no other case has been reported in a patient treated with the anti-CD40 monoclonal antibody. CASE PRESENTATION: A 49-year-old patient, 1.5 years after primary kidney transplantation, presented with vocal cord problems, a dry irritating cough, and a sore throat. A detailed investigation, including a high-resolution chest CT scan, revealed the diagnosis of disseminated tuberculosis. The antituberculosis treatment consisting of rifampicin, isoniazid, pyrazinamide, and ethambutol was started immediately. The patient's condition became complicated by relapsing diarrhoea. The colonoscopy revealed a circular stenosis above Bauhin's valve. Microscopical findings showed active colitis and vaguely formed collections of epithelioid macrophages without fully developed caseous granulomas and were consistent with the clinical diagnosis of tuberculosis. The antituberculosis treatment was subsequently enhanced by moxifloxacin and led to a great improvement in the patient's condition. CONCLUSION: In this case, false negativity of interferon-γ release assays and possibly higher risk for intracellular infections in patients on costimulatory signal blockers are discussed.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22024799
003      
CZ-PrNML
005      
20221031100042.0
007      
ta
008      
221017s2022 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s12882-022-02916-2 $2 doi
035    __
$a (PubMed)35986231
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Bednarova, Kamila $u Department of Nephrology, Transplant Center, Institute for Clinical and Experimental Medicine, Videnska 1958/9, 14021, Prague, Czech Republic $u 1St Medical Faculty, Charles University, Prague, Czech Republic
245    10
$a Tuberculosis dissemination in kidney transplant recipient treated with anti-CD40 monoclonal antibody: a case report / $c K. Bednarova, J. Slatinska, O. Fabian, P. Wohl, E. Kopecka, O. Viklicky
520    9_
$a BACKGROUND: Tuberculosis (TBC) in solid organ transplant recipients represents a severe complication. The incidence among transplant recipients is higher than in the general population, and the diagnosis and treatment remain challenging. We present a case of active disseminated tuberculosis in a kidney transplant recipient treated with an anti-CD40 monoclonal antibody, who had been previously exposed to an active form of the disease, but latent tuberculosis (LTBI) was repeatedly ruled out prior to transplantation. To the best of our knowledge, no other case has been reported in a patient treated with the anti-CD40 monoclonal antibody. CASE PRESENTATION: A 49-year-old patient, 1.5 years after primary kidney transplantation, presented with vocal cord problems, a dry irritating cough, and a sore throat. A detailed investigation, including a high-resolution chest CT scan, revealed the diagnosis of disseminated tuberculosis. The antituberculosis treatment consisting of rifampicin, isoniazid, pyrazinamide, and ethambutol was started immediately. The patient's condition became complicated by relapsing diarrhoea. The colonoscopy revealed a circular stenosis above Bauhin's valve. Microscopical findings showed active colitis and vaguely formed collections of epithelioid macrophages without fully developed caseous granulomas and were consistent with the clinical diagnosis of tuberculosis. The antituberculosis treatment was subsequently enhanced by moxifloxacin and led to a great improvement in the patient's condition. CONCLUSION: In this case, false negativity of interferon-γ release assays and possibly higher risk for intracellular infections in patients on costimulatory signal blockers are discussed.
650    _2
$a monoklonální protilátky $x terapeutické užití $7 D000911
650    12
$a protinádorové látky $7 D000970
650    _2
$a antituberkulotika $x terapeutické užití $7 D000995
650    _2
$a lidé $7 D006801
650    12
$a transplantace ledvin $x škodlivé účinky $7 D016030
650    _2
$a lidé středního věku $7 D008875
650    _2
$a příjemce transplantátu $7 D066027
650    12
$a tuberkulóza $x diagnóza $x farmakoterapie $x epidemiologie $7 D014376
655    _2
$a kazuistiky $7 D002363
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Slatinska, Janka $u Department of Nephrology, Transplant Center, Institute for Clinical and Experimental Medicine, Videnska 1958/9, 14021, Prague, Czech Republic
700    1_
$a Fabian, Ondrej $u Clinical and Transplant Pathology Centre, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Wohl, Pavel $u Department of Hepatogastroenterology, Transplant Centre, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Kopecka, Emilia $u Department of Respiratory Medicine, 1St Faculty of Medicine of Charles University and Thomayer Hospital, Prague, Czech Republic
700    1_
$a Viklicky, Ondrej $u Department of Nephrology, Transplant Center, Institute for Clinical and Experimental Medicine, Videnska 1958/9, 14021, Prague, Czech Republic. ondrej.viklicky@ikem.cz $u Transplant Laboratory, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. ondrej.viklicky@ikem.cz
773    0_
$w MED00008194 $t BMC nephrology $x 1471-2369 $g Roč. 23, č. 1 (2022), s. 290
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35986231 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20221017 $b ABA008
991    __
$a 20221031100040 $b ABA008
999    __
$a ok $b bmc $g 1854498 $s 1176089
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 23 $c 1 $d 290 $e 20220819 $i 1471-2369 $m BMC nephrology $n BMC Nephrol $x MED00008194
LZP    __
$a Pubmed-20221017

Find record

Citation metrics

Archiving options